P-MSC/TERT308 as model to optimize cellular cytotoxicity assay

May 27th, 2025, Vienna, Austria

We are pleased to share a new research note from partners within the EU-funded LifeSaver Project, featuring the use of our P-MSC/TERT308 placenta-derived mesenchymal stromal cells to optimize the widely used resazurin-based cellular viability assay.

Read the full research note here.